Research & Development: Page 84
-
PharmaVoice Team/PharmaVoice
E-Media
76 J u n e 20 03 PharmaVOICE EMEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Choice Media has expanded its health newscov erage through an agreement with Ivanhoe Broad cast News, a newsgathering organization covering medical information for television stations. The rela t...
By PharmaVoice Team • April 16, 2008 -
PharmaVoice Team/PharmaVoice
What's New
PharmaVOICE WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Carbon Healthcare Communications, a new division of CommonHealth,has been launched as a professional advertising and promotion agency to serve the needs of “highscience”brands. The agen cy is targeting biopharmaceutica...
By PharmaVoice Team • April 16, 2008 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
PharmaTrax
66 J u n e 20 03 PharmaVOICE PHARMA TRAX SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY 56 MILLION U.S. ADULTS GOONLINE for Information on Chronic Health Conditions Data gathered by Manhattan Research LLC’s ePharma Analytical Insight Module (AIM) reveals that 56.3 million ...
By PharmaVoice Team • April 16, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Advertising campaign for Allegra represents an original and refreshing approach to the patient type challenge. In a welcome departure from the tradi tional patientinyourface approach, it uses a variety of different vehicles and complementing hats that clearly say Allegra is for a ...
By PharmaVoice Team • April 16, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
The marketplace is fast approaching 100,000 sales representatives, and reports in The Wall Street Journal suggest that physicians aren’t influenced by what representatives are saying. The question is: Why are there so many reps who can’t seem to get their message across? Adding more representativ...
By Charles Brennan • April 16, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
3 PharmaVOICE J un e 2003 PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski MANAGING EDITOR Denise Myshko CONTRIBUTING EDITORS Elisabeth Pena Kim Ribbink Lynda Sears Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Vo...
By Taren Grom • April 16, 2008 -
PharmaVoice Team/PharmaVoice
Building a Corporate Identity
8 J u l y 2 00 3 PharmaVOICE E M For the first time, individual companies must establish their own identity with consumers. Executives should focus on identifying their company’s most unique and positive characteristics and communicate them in a single, simple message that can be translated for e...
By Kim Ribbink • April 16, 2008 -
PharmaVoice Team/PharmaVoice
Wendell J. Knox- Business With Integrity
A contract for strengthening the health system in postconflict Iraq. In its Domestic Social and Economic Poli cy group, Abt Associates works with a wide range of government agencies, including the Environmental Protection Agency, for whom it helps to improve policies and regulations to reduce pol...
By Kim Ribbink • April 16, 2008 -
PharmaVoice Team/PharmaVoice
The Lessons of Greed
38 J u l y 20 03 PharmaVOICE TWASALLABOUTMONEY. That’s how Bruce I. Diamond, Ph.D., describes how he, a distinguished professor and clinical researcher, ended up in prison for theft and misrepresentation. Dr. Diamond, a pharmacologist, is a former professor with the department of psychiatry and f...
By PharmaVoice Team • April 16, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
July 1718,2003,The Watergate Hotel — Washington,D.C. Metabonomics Industry experts will address understanding the metabolic signatures of disease in the postgenomic era; applying metabonomics to toxicity screening and mechanism of action studies; and realizing the potential of metabonomics as an ...
By PharmaVoice Team • April 10, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
50 J u l y 20 03 PharmaVOICE PHARMA TRAX SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY Study Suggests Physicians Want to Hear from REPSWITH OBJECTIVE INFORMATION A study from J. Scott International Inc. suggests that doctors are more likely to write prescriptions if they ...
By PharmaVoice Team • April 10, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
In nearly every aspect of today’s society, we enjoy the benefits and the efficiencies of technology’s impact. We buy theater and plane tickets online, travel with directions from global posi tioning satellites, and accomplish everything from paying bills to making dinner reservations and then ins...
By John M. Hudak • April 10, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
RAISE your voice Resultsoriented partnerships We read with great interest the incisive recommendations of our friend Richard B. Vanderveer, CEO of V2 Inc., on the need to redefine the drivers of and acquisition process es for successful pharmaceutical company/ven dor relationships. (“The shifting...
By PharmaVoice Team • April 10, 2008 -
PharmaVoice Team/PharmaVoice
Global Clinical Connections
Building Relationship Bridges Forming a winning CRO/sponsor partnership requires trust, communication, and understand ing the expectations and needs of the other party. Using advanced technology for communi cations, taking ownership, and getting to know your partner can ensure these elements are ...
By Robin Robinson • March 31, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
James King,M.D.,FAAFP,was named Presidentelect of the American Academy of Family Physicians (AAFP) in September 2006.Previously,he served three years as a director on the AAFP board.He also serves as volunteer faculty at the University of Tennessee Center for Health Sciences, is on the medical st...
By PharmaVoice Team • March 29, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Managing MultiJurisdictional Legal and Regulatory Risks in Clinical Trials Renaissance Brussels Hotel,Brussels,Belgium For more information, contact Cordelia Ekeocha,C5,at 442078786929, email [email protected], or visit c5online.com. April 16–17 Pharma Marketing Research Essentials Seminar S...
By PharmaVoice Team • March 29, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Clinical Ink has introduced clinicalink.com, a Website that provides corporate information and detailed explanations of the Clinical Ink eSource solution for the electronic capture and storage of data during clinical trials. The co...
By PharmaVoice Team • March 29, 2008 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Publicis Selling Solutions Group has created a new divi sion, Publicis Clinical Health Partners, focused on providing integrated behaviorally based education programs for patients and healthcare professionals to optimize patient compliance a...
By PharmaVoice Team • March 29, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
GOLD STANDARD IN ASTHMA TREATMENT is Expected to Emerge A report by Decision Resources projects that for moterol/mometasone, an asthma therapy codevel oped by ScheringPlough and Novartis, will be approved in 2009 and become the clinical gold standard for treating asthma by 2011 because of its com...
By PharmaVoice Team • March 29, 2008 -
PharmaVoice Team/PharmaVoice
25 Years of the Orphan Drug Act
Synthetic drugs accounted for 62% of total orphan drug approvals, and synthetic polypep tides and hormones together accounted for 6%. Among biologics, growth hormones and growth factors together have the largest num ber of approvals at 8% of the total. Market approvals received for plasma product...
By Cynthia Borda • March 27, 2008 -
PharmaVoice Team/PharmaVoice
The Softer Side of R&D
Industry experts say the technical competencies of drug development have to be combined with the softer skills of change management and leadership ability. R&D leaders will have to work in global teams to manage the output from their partners. This will require highly trained technical specia...
By Denise Myshko • March 27, 2008 -
PharmaVoice Team/PharmaVoice
Proof of Concept
BENEFITS OF EXPLORATORY INDS In a guidance released in January 2006, the FDA laid out specific approaches for researchers George Mills, M.D., VP, medical imaging consulting, for Perceptive Informatics at Parexel International, agrees that an exploratory IND is an avenue to evaluate the preclinica...
By Denise Myshko • March 27, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Milestones 20 YEARS OF DISCOVERY Pharmaceutical Research and Manufacturers of America (PhRMA) has marked the 20th anniversary of the Discoverers Award, the highest honor given by PhRMA to scientists who helped discover breakthrough medicines for patients suffering from disease. PhRMA presented th...
By PharmaVoice Team • March 27, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice — Letters
A Missing Link I just finished reading the March article, “Strengthening the Clinical Recruitment Chain,” and it seems to me that you forgot a crucial first step in the process you describe. This would be the establishment of a sound protocol that makes scientific sense and benefits the subject. ...
By PharmaVoice Team • March 27, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Bogey and Bacall, Rogers and Hammerstein,Ben & Jerry,or closer to home John K. Smith, Thomas Beecham, and Mahlon Kline — great partners who made for great partnerships. In developing this issue, an inadvertent theme developed, one centered around the concept of partner ships. What makes them ...
By PharmaVoice Team • March 27, 2008
Previous
